BALYASNY ASSET MANAGEMENT L.P. - UNIQURE NV ownership

UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 41 filers reported holding UNIQURE NV in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of UNIQURE NV
ValueSharesWeighting
Q2 2023$6,939,202
+2.5%
605,515
+80.2%
0.02%
-11.8%
Q1 2023$6,768,369
-49.1%
336,066
-52.9%
0.02%
-60.5%
Q2 2022$13,295,000
+200.9%
713,240
+191.7%
0.04%
+207.1%
Q1 2022$4,418,000
+888.4%
244,487
+1034.8%
0.01%
+600.0%
Q4 2021$447,000
-88.4%
21,545
-79.4%
0.00%
-92.9%
Q3 2020$3,849,000
+415.3%
104,500
+563.7%
0.03%
+211.1%
Q1 2020$747,000
-91.7%
15,745
-87.5%
0.01%
-83.3%
Q4 2019$9,046,000
+933.8%
126,236
+467.6%
0.05%
+800.0%
Q3 2019$875,000
-90.4%
22,242
-80.1%
0.01%
-89.7%
Q2 2019$9,080,000
+1772.2%
111,795
+1276.3%
0.06%
+1833.3%
Q1 2019$485,000
-91.6%
8,123
-94.9%
0.00%
-88.5%
Q3 2018$5,767,000
+41.3%
158,471
+46.7%
0.03%
+36.8%
Q2 2018$4,082,000
+15.9%
108,000
-37.3%
0.02%
-26.9%
Q3 2015$3,523,000
+588.1%
172,292
+719.0%
0.03%
+550.0%
Q1 2015$512,00021,0380.00%
Other shareholders
UNIQURE NV shareholders Q1 2015
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 841,471$15,786,0005.69%
Nantahala Capital Management 2,901,929$54,440,0003.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 544,500$10,209,0003.27%
683 Capital Management, LLC 1,373,600$25,768,0001.99%
PFM Health Sciences, LP 2,393,311$44,899,0001.62%
Integral Health Asset Management, LLC 433,000$8,123,0001.58%
Privium Fund Management B.V. 238,998$4,283,0001.56%
Nantahala Capital Management 1,000,000$18,760,0001.21%
Henry James International Management Inc. 89,469$1,678,0000.94%
Altium Capital Management LP 105,000$1,970,0000.72%
View complete list of UNIQURE NV shareholders